Charlotte Butler

Laboratory Analyst at Camallergy
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Portsmouth Area, UK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Camallergy
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Laboratory Analyst
      • May 2022 - Present

      “Pioneering treatments for food allergies. Peanut allergy affects 1.4 to 3% of children in high-income countries - around 6 million in Europe and the US - and there is no licensed treatment. Camallergy is developing a treatment that showed 84 and 91% success in phase 2, and is preparing for confirmatory phase 3 studies.” “Pioneering treatments for food allergies. Peanut allergy affects 1.4 to 3% of children in high-income countries - around 6 million in Europe and the US - and there is no licensed treatment. Camallergy is developing a treatment that showed 84 and 91% success in phase 2, and is preparing for confirmatory phase 3 studies.”

  • Resolian UK
    • United Kingdom
    • Biotechnology Research
    • 100 - 200 Employee
    • Scientist
      • Mar 2021 - May 2022

  • LGC
    • United Kingdom
    • Biotechnology Research
    • 700 & Above Employee
    • Student scientist
      • Jul 2018 - Aug 2019

Education

  • University of Surrey
    BSc(Hons), Chemistry
    2016 - 2021

Community

You need to have a working account to view this content. Click here to join now